Global female fertility and pregnancy rapid test market is expected to register a CAGR of around 5% over the period of 2021-2027. This is mainly due to the rising female aging population, surging number of infertility cases, growing hormonal disorders, and rising awareness regarding female fertility and pregnancy rapid test devices coupled with the growing focus of major stakeholders in the beauty industry to adopt to make beauty products more sustainable with and eco-friendlier. Major healthcare companies are investing heavily in their products due to the growing average age of first-time pregnancy has increased drastically across the globe. According to CDC, in 2019, about 6% of married women aged 15-44 years in the United States were unable to conceive after one year of trying. Moreover, about 12% of women aged 15-44 years in the United States have difficulty conceiving or sustaining a pregnancy. Furthermore, various factors such as hormonal imbalance can cause disorders such as PCOS (polycystic ovary syndrome), indescribable miscarriages, and the emergence of advanced ovulation monitors, which are responsible for excessive use of female fertility and pregnancy rapid tests. Therefore, the market for female fertility and pregnancy rapid tests is expected to witness significant growth during the forecast period.
Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21037
According to UnivDatos Market Insights (UMI)’ research report “global female fertility and pregnancy rapid test market”, the market is expected to witness robust growth during the forecast period 2021-2027F. This is mainly due to the increasing aging population and fast and self-contained tests, and awareness regarding the safety of women’s health among consumers. For Instance, in June 2021, BioMerieux announced the distribution of specific diagnostics’ REVEAL Rapid AST system in Europe which strengthen the rapid testing kits segment of the market in the European region. The specific reveal rapid AST system delivers phenotypic AST results in an average of 5 hours, directly from positive blood culture. Thus, with the growing focus on technology the specific reveal is easy to use, has high throughput, and provides accurate minimum inhibitory concentration (MIC) results with wide antimicrobial coverage. Furthermore, REVEAL Rapid AST offers customers an easy-to-use instrument with a targeted menu, small footprint, and modular design well-suited for a large number of hospitals.
Based on device type, the market is classified into digital devices and line-indicator devices. Amongst types, the line-indicator devices category accounted for a significant share of the market. This is mainly due to the presence of a wide range of products and the advent of novel and improved methods that include mid-stream devices, strip/dipsticks, and cassettes. Thus, these medical devices have a method of test format is another factor that can influence the accuracy of pregnancy tests when used at home, their demand is increasing across the globe. Over the forthcoming years, the rising popularity of home-based diagnostic testing products among the younger generation is likely to boost the demand for female fertility and pregnancy rapid tests remarkably, worldwide.
Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21037
Based on product, the market is categorized into fertility rapid test kits and pregnancy rapid test kits. Among these, the pregnancy rapid test kits are expected to witness the highest CAGR during the forecast period. The pregnancy rapid test kits are growing the number of adolescent pregnancies and are expected to support the growth of the segment over the forecast period. According to the Centers for Disease Control, one in eight couples has trouble conceiving or sustaining a pregnancy, due to age, health issues, or other factors. This indicates that there is a need in the market for cost-efficient and accurate ovulation monitors.
North America to witness extensive growth
For a better understanding of the market adoption of the female fertility and pregnancy rapid test industry, the market is analyzed based on its worldwide presence in the countries such as North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest of World. North America is expected to witness a significant CAGR during the forecast period on account of growing various devices, the rise in first-time pregnancy age, and the availability of less time-consuming decentralized diagnostic tests in place of laboratory tests have boosted the market growth. The increased consumer awareness regarding the availability of various fertility as well as pregnancy rapid test kits. Furthermore, the increasing prevalence of gynecological disorders and infertility and fast and self-contained tests, new product launches, and various developmental strategies adopted by the regional market will drive market growth.
For more informative information, please visit us – https://univdatos.com/report/female-fertility-and-pregnancy-rapid-test-market/
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global Female fertility and pregnancy rapid test market are BioMerieux, Abbott, Church & Dwight, Quidel, Clinical Guard, Fairhaven Health, PRIMA Lab, Princeton BioMeditech, Wondfo, and Mankind Pharma are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.
“Global Female Fertility and Pregnancy Rapid Test Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.
For more informative information, please visit us – https://univdatos.com/report/female-fertility-and-pregnancy-rapid-test-market/
Market Segmentation:
- By Device Type (Digital Devices and Line-indicator Devices)
- By Test Type (FSH Urine Test, LH Urine Test, hCG Blood Test, and hCG Urine Test)
- By Product (Fertility Rapid Test Kits and Pregnancy Rapid Test Kits)
- By Distribution Channel (Retail Stores, Online Stores, Gynecology and Fertility Clinics, and Other)
- By Region (North America, Europe, Asia-Pacific, Rest of the World)
- By Company (BioMerieux, Abbott, Church & Dwight, Quidel, Clinical Guard, Fairhaven Health, PRIMA Lab, Princeton BioMeditech, Wondfo, and Mankind Pharma)
Key questions answered in the study:
- What are the current and future trends of the global female fertility and pregnancy rapid test industry?
- How the industry has been evolving in terms of technology and application?
- How the competition has been shaping across the countries followed by their comparative factorial indexing?
- What are the key growth drivers and challenges for the global female fertility and pregnancy rapid test industry?
- What is the customer orientation, purchase behavior, and expectations from the global female fertility and pregnancy rapid test suppliers across various region and countries?
Table of Content –
1 MARKET INTRODUCTION
2 RESEARCH METHODOLOGY OR ASSUMPTION
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 GLOBAL FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET COVID-19 IMPACT
6 GLOBAL FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET REVENUE (USD BN), 2019-2027F
7 MARKET INSIGHTS BY DEVICE TYPE
8 MARKET INSIGHTS BY TEST TYPE
9 MARKET INSIGHTS BY PRODUCT
10 MARKET INSIGHTS BY DISTRIBUTION CHANNEL
11 MARKET INSIGHTS BY REGION
12 FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET DYNAMICS
13 FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET OPPORTUNITIES
14 FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET TRENDS
15 POLICY & REGULATORY FRAMEWORK
16 DEMAND AND SUPPLY-SIDE ANALYSIS
17 VALUE CHAIN ANALYSIS
18 COMPETITIVE SCENARIO
19 COMPANY PROFILED
20 DISCLAIMER
About Us:
UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.
Contact us:
UnivDatos Market Insights (UMI)
Email: sales@univdatos.com
Ph: +91 7838604911